FDA DEVICE FACTS
INSTANT-VIEW plus Multi-Drug of Abuse Urine Test - Simple Cup (OTC Use), INSTANT-VIEW plus Multi-Drug Urine Test - Simple Cup (Prescription Use)
Alfa Scientific Designs, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The INSTANT-VIEW plus Multi-Drug of Abuse Urine Test - Simple Cup (OTC Use) device is a rapid, qualitative immunoassay device for the detection of one or more drugs or metabolites at the designated cutoff concentrations in human urine. The device can detect up to 13 drugs or their metabolites: Analyte Calibrator Cutoff (ng/mL) Amphetamines d-Amphetamine 1000 Barbiturates Secobarbital 200 Buprenorphine Buprenorphine 10 Benzodiazepines Oxazepam 300 Cocaine Benzoylecgonine 300 Methamphetamine d-Methamphetamine 1000 Methadone Methadone 300 Phencyclidine Phencyclidine 25 Tricyclic Antidepressants Nortriptyline 1000 Cannabinoids 11-nor-Δ9-THC-9-COOH 50 MDMA Methylenedioxy-methamphetamine 500 Morphine Morphine 2000 Oxycodone Oxycodone 300 These a ssays may yield positive results when barbiturates, benzodiazepines, or tricyclic antidepressants are ingested at or above therapeutic doses. There are no uniformly recognized cutoff levels for barbiturates, benzodiazepines, or tricyclic antidepressants in urine. The assays are not intended to distinguish between prescription use or abuse of these drugs. This device provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Chromatography/mass spectrometry is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are obtained. The INSTANT-VIEW plus Multi-Drug Urine Test - Simple Cup (Prescription Use) device is a rapid, qualitative immunoassay device for the detection of one or more drugs or metabolites at the designated cutoff concentrations in human urine. The device can detect up to 13 drugs or their metabolites: Analyte Calibrator Cutoff (ng/mL) Amphetamines d-Amphetamine 1000 Barbiturates Secobarbital 200 Buprenorphine Buprenorphine 10 Benzodiazepines Oxazepam 300 Cocaine Benzoylecgonine 300 Methamphetamine d-Methamphetamine 1000 Methadone Methadone 300 Phencyclidine Phencyclidine 25 Tricyclic Antidepressants Nortriptyline 1000 Cannabinoids 11-nor-Δ9-THC-9-COOH 50 MDMA Methylenedioxy-methamphetamine 500 Morphine Morphine 2000 Oxycodone Oxycodone 300 T hese assays may yield positive results when barbiturates, benzodiazepines, or tricyclic antidepressants are ingested at or above therapeutic doses. There are no uniformly recognized cutoff levels for barbiturates, benzodiazepines, or tricyclic antidepressants in urine. The assays are not intended to distinguish between prescription use or abuse of these drugs. This device provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Chromatography/mass spectrometry is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are obtained.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。